Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer
- PMID: 29386089
- PMCID: PMC7844703
- DOI: 10.3727/096504018X15166193231711
Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer
Retraction in
-
Retraction: Long noncoding RNA GAS5 promotes proliferation, migration, and invasion by regulation of miR-301a in esophageal cancer.Oncol Res. 2024 Oct 16;32(11):1823. doi: 10.32604/or.2024.056896. eCollection 2024. Oncol Res. 2024. PMID: 39449810 Free PMC article.
Abstract
Long noncoding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) has been revealed to be associated with the progression of various cancers. However, the biological roles of GAS5 in esophageal cancer (EC) remain unclear. We aimed to thoroughly explore the functions of GAS5 in EC. The results showed that GAS5 expression was increased in EC cells (ECA109, TE-1, TE-3, and EC9706) compared to SHEE cells. Knockdown of GAS5 decreased cell viability, migration, and invasion and induced apoptosis in EC9706 cells. Moreover, miR-301a appeared to be directly sponged by GAS5, and miR-301a suppression obviously alleviated the protumor effects of GAS5. Furthermore, miR-301a positively regulated CXCR4 expression, and overexpression of CXCR4 induced apoptosis and abolished the promoting effect of miR-301a inhibition on cell viability, migration, and invasion. Besides, miR-301a blocked Wnt/β-catenin and NF-κB signaling pathways by regulation of CXCR4. Our results indicated that GAS5 promoted proliferation and metastasis and inhibited apoptosis by regulation of miR-301a in EC. These data contributed to our understanding of the mechanisms of miRNA-lncRNA interaction and provides a novel therapeutic strategy for EC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures







Similar articles
-
Knockdown of Urothelial Carcinoma-Associated 1 Suppressed Cell Growth and Migration Through Regulating miR-301a and CXCR4 in Osteosarcoma MHCC97 Cells.Oncol Res. 2018 Dec 27;27(1):55-64. doi: 10.3727/096504018X15201143705855. Epub 2018 Mar 9. Oncol Res. 2018. Retraction in: Oncol Res. 2024 Jul 17;32(8):1381. doi: 10.32604/or.2024.055035. PMID: 29523218 Free PMC article. Retracted.
-
LncRNA PCAT18/miR-301a/TP53INP1 axis is involved in gastric cancer cell viability, migration and invasion.J Biochem. 2020 Nov 1;168(5):547-555. doi: 10.1093/jb/mvaa079. J Biochem. 2020. PMID: 32687182
-
Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.Biomed Pharmacother. 2020 Mar;123:109650. doi: 10.1016/j.biopha.2019.109650. Epub 2019 Dec 26. Biomed Pharmacother. 2020. PMID: 31884338
-
Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological Functions.Int J Mol Sci. 2021 Jun 24;22(13):6810. doi: 10.3390/ijms22136810. Int J Mol Sci. 2021. PMID: 34202777 Free PMC article. Review.
-
Dysregulation of GAS5-miRNA-Mediated Signaling Pathways in Cancer Pathobiology: A Comprehensive Exploration of Pathways Influenced by this Axis.Biochem Genet. 2025 Apr;63(2):1149-1175. doi: 10.1007/s10528-024-10997-x. Epub 2024 Dec 24. Biochem Genet. 2025. PMID: 39718723 Review.
Cited by
-
Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics.Int J Biol Sci. 2023 Jul 31;19(12):3831-3868. doi: 10.7150/ijbs.85753. eCollection 2023. Int J Biol Sci. 2023. PMID: 37564206 Free PMC article. Review.
-
The role of long non-coding RNA GAS5 in cancers.Cancer Manag Res. 2019 Apr 8;11:2729-2737. doi: 10.2147/CMAR.S189052. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114330 Free PMC article.
-
Zoledronic Acid Accelerates Bone Healing in Carpal Navicular Fracture via Silencing Long Non-coding RNA Growth Arrest Specificity 5 to Modulate MicroRNA-29a-3p Expression.Mol Biotechnol. 2024 Nov;66(11):3238-3251. doi: 10.1007/s12033-023-00931-8. Epub 2023 Oct 20. Mol Biotechnol. 2024. PMID: 37861953
-
Single Nucleotide Polymorphisms (SNPs) in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer.Curr Pharm Biotechnol. 2024;25(15):1915-1938. doi: 10.2174/0113892010265004231116092802. Curr Pharm Biotechnol. 2024. PMID: 38310451 Review.
-
The Nefarious Nexus of Noncoding RNAs in Cancer.Int J Mol Sci. 2018 Jul 17;19(7):2072. doi: 10.3390/ijms19072072. Int J Mol Sci. 2018. PMID: 30018188 Free PMC article. Review.
References
-
- Cools-Lartigue J, Spicer J, Ferri LE. Current status of management of malignant disease: Current management of esophageal cancer. J Gastrointest Surg. 2015;19(5):964–72. - PubMed
-
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2095–128. - PMC - PubMed
-
- Mir MR, Rajabpour MV, Delarestaghi MM, Hadji M, Harirchi I, Mir P, Mir A, Lashkari M, Zendehdel K. Short- and long-term survival of esophageal cancer patients treated at the Cancer Institute of Iran. Dig Surg. 2013;30(4–5):331–6. - PubMed
-
- Aghajanzadeh M, Rahimi A, Emami D, Aghajanzadeh G, Jahromi SK, Ebrahimi H. A comparison of survival with chemoradiation therapy alone versus surgery and post-esophagectomy chemoradiation in patients with esophageal carcinoma. Nishinihon J Urol. 2014;2(4):350–2.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical